株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

手術部位感染防止の世界市場:成長、動向、予測(2019〜2024年)

Surgical Site Infection Control Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 802343
出版日 ページ情報 英文 118 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.74円で換算しております。
Back to Top
手術部位感染防止の世界市場:成長、動向、予測(2019〜2024年) Surgical Site Infection Control Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年03月01日 ページ情報: 英文 118 Pages
概要

現在、世界の手術部位感染防止市場は成長段階にあり、北米などの先進国や病院などに独占されています。増加する院内感染や手術件数の増加が市場の成長を促進しています。

当レポートでは、世界の手術部位感染防止市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場動向

  • 市場概要
  • 市場促進因子
    • 院内感染の増加
    • 病院感染防止と管理に関する規制ガイドライン
    • 手術件数の増加
    • 急速な高齢化
  • 市場阻害因子
    • 院内感染防止と管理に対する認識不測
    • 外来治療の使用拡大
  • ポーターズファイブフォース分析

第5章 市場セグメンテーション

  • 製品別
    • 手動再処理剤
    • 消毒剤
    • 手術用石鹸
    • ヘアクリッパー
    • 手術用ドレープ
    • 手術用水利管理
    • 皮膚処理剤
    • 医療用不織布
    • 手術用手袋
    • その他
  • 手術/手技別
    • 白内障手術
    • 帝王切開
    • 歯科修復
    • 胃バイパス
    • その他
  • 感染タイプ別
    • 表面切開感染
    • 深部切開感染
    • 臓器・空間感染
  • エンドユーザー別
    • 病院
    • 外来外科センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合環境

  • 企業プロファイル
    • 3M
    • Becton, Dickinson and Company
    • Belimed AG
    • bioMerieux SA
    • Getinge Group
    • Johnson & Johnson
    • Kimberly-Clark Corporation
    • Sotera Health
    • Ansell Limited
    • Steris Corporation
    • Lac-Mac Limited
    • Pacon Manufacturing Corp.
    • American Polyfilm Inc.

第7章 市場の機会と将来動向

目次
Product Code: 61068

Market Overview

Currently, the global SSI control market is in the growing phase and is dominated by hospitals and developed regions, like North America. Increasing hospital-acquired infections and number of surgeries are increasingly driving the SSI control market across the world. Increased focus on preventing SSI through appropriate measures has further augmented the market in developed regions. Awareness about surgical site infections is also higher in the developed regions. This has led to higher adoption of SSI control products, thus, preventing infections among people. The increasing geriatric population has also impacted this market positively.

Scope of the Report

As per the scope of this report, surgical site infection (SSI) is an infection that occurs after surgery, in that part of the body where the surgery has been done. Surgical site infections can be superficial, deep incisional, or organ related.

Key Market Trends

Superficial Incisional SSI Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Surgical site infection (SSI) represents the most common nosocomial infection and accounts for about 15% of all nosocomial infections. Surgical site infection is one of the most common complications of gastrointestinal surgery. This type of surgical procedures and wound closure methods affect the incidence of superficial incisional surgical site infection. There is an increase in the incidence of superficial incisional SSI infections, as compared to deep incisional SSI and organ or space SSIs.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the surgical site infection control market, with the United States contributing the largest share in the regional revenue. SSIs are considered the most common (tied with pneumonia) healthcare-associated infection (HAI) among inpatients in acute care hospitals in the United States. SSIs occur in an estimated 2-5% of patients undergoing inpatient surgery. The estimated annual incidence of SSIs in the United States ranges from 160,000 to 300,000, and the estimated annual cost ranges from USD 3.5 billion to USD 10 billion. Hence, the rising need for the prevention of SSI can be attributed to the rising number of surgical procedures performed in the United States.

Competitive Landscape

3M Company, Becton, Dickinson and Company, Biomerieux SA, Getinge Grou,p and Johnson & Johnson are some of the major players in the surgical site infection control market The competitive rivalry of the market studied has intensified, owing to the constant product innovations across the world.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Hospital Acquired Infection
    • 4.2.2 Regulatory Guidelines for Hospital Infection Prevention and Control
    • 4.2.3 Increasing Number of Surgeries
    • 4.2.4 Rapidly Growing Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness of Hospital Infection Prevention and Control
    • 4.3.2 Increased Use of Outpatient Treatment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Manual Reprocessors Solution
    • 5.1.2 Disinfectants
      • 5.1.2.1 Hand Disinfectants
      • 5.1.2.2 Skin Disinfectants
    • 5.1.3 Surgical Scrubs
    • 5.1.4 Hair Clippers
    • 5.1.5 Surgical Drapes
    • 5.1.6 Surgical Irrigation
    • 5.1.7 Skin Preparation Solution
    • 5.1.8 Medical Nonwovens
    • 5.1.9 Surgical Gloves
    • 5.1.10 Other Products
  • 5.2 By Surgery/Procedure
    • 5.2.1 Cataract Surgery
    • 5.2.2 Cesarean Section
    • 5.2.3 Dental Restoration
    • 5.2.4 Gastric Bypass
    • 5.2.5 Other Surgeries/Procedures
  • 5.3 By Type of Infection
    • 5.3.1 Superficial Incisional SSI
    • 5.3.2 Deep Incisional SSI
    • 5.3.3 Organ or Space SSI
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Ambulatory Surgical Centers
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Belimed AG
    • 6.1.4 bioMerieux SA
    • 6.1.5 Getinge Group
    • 6.1.6 Johnson & Johnson
    • 6.1.7 Kimberly-Clark Corporation
    • 6.1.8 Sotera Health
    • 6.1.9 Ansell Limited
    • 6.1.10 Steris Corporation
    • 6.1.11 Lac-Mac Limited
    • 6.1.12 Pacon Manufacturing Corp.
    • 6.1.13 American Polyfilm Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top